Fig. 2

Elevated MTSS1 mRNA expression is associated with poor prognosis. a the qRT-PCR analysis of MTSS1 expression in different groups, P = 0.000, when compared with controls. b MMP2 activity in residual HCC (HCC-P II group); †P = 0.000, when compared with controls; no difference in MTSS1 mRNA level or MMP2 activity between HCC-P I and HCC-R groups. c earlier detection of residual HCC in MTSS1-high group than in MTSS1-low group, *P = 0.000. d higher number of lung metastatic nodules in MTSS1-high group than in MTSS1-low group, *P = 0.039, when compared with controls. e longer survival in MTSS1-low group compared with MTSS1-high group, P = 0.023